Logo
x

Search

Subscribe Now

Global

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

  • October 13, 2021
Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

Roche Reports Results of Faricimab in Four P-III Studies for Diabetic Macular Edema and Age-Related Macular Degeneration

  • February 12, 2021
Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis

Incyte Collaborates with Cellenkos for CK0804 to Treat Myelofibrosis

  • December 31, 2020
Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

Roche Reports Results of Faricimab in Two Global P-III Studies for Diabetic Macular Edema

  • December 22, 2020
J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

  • September 24, 2020
Roche and UCB Collaborate to Develop UCB0107 for Alzheimer's Disease

Roche and UCB Collaborate to Develop UCB0107 for Alzheimer's Disease

  • July 29, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.